Aztreonam penetration into synovial fluid and bone
- PMID: 3707115
- PMCID: PMC180473
- DOI: 10.1128/AAC.29.4.710
Aztreonam penetration into synovial fluid and bone
Abstract
Eighteen patients with uncomplicated degenerative joint disease requiring joint replacement (hip or knee) were given a single 2-g intravenous dose of aztreonam over a 5-min period preoperatively. The mean concentration in synovial fluid of 83.0 +/- 9.2 micrograms/ml averaged 0.99 times the concomitant levels in serum. The mean concentration in cancellous bone of 16.0 +/- 4.3 micrograms/g averaged 0.20 times the concomitant levels in serum.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
